These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16759760)

  • 1. Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge.
    Liu WT; Lin WT; Tsai CC; Chuang CC; Liao CL; Lin HC; Hung YW; Huang SS; Liang CC; Hsu HL; Wang HJ; Liu YT
    Vaccine; 2006 Jul; 24(31-32):5852-61. PubMed ID: 16759760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of amphotericin B upon enhancement of protective immunity elicited by oral administration with liposome-encapsulated-Japanese encephalitis virus nonstructural protein 1 (NS1) in mice.
    Lin TS; Chuang CC; Hsu HL; Liu YT; Lin WP; Liang CC; Liu WT
    Microb Pathog; 2010 Sep; 49(3):67-74. PubMed ID: 20412849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model.
    Mellado-Sánchez G; García-Machorro J; Sandoval-Montes C; Gutiérrez-Castañeda B; Rojo-Domínguez A; García-Cordero J; Santos-Argumedo L; Cedillo-Barrón L
    Arch Virol; 2010 Jun; 155(6):847-56. PubMed ID: 20390312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus.
    Fu YH; He JS; Wang XB; Zheng XX; Wu Q; Xie C; Zhang M; Wei W; Tang Q; Song JD; Qu JG; Hong T
    Biochem Biophys Res Commun; 2010 Apr; 395(1):87-92. PubMed ID: 20350532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy.
    Vindurampulle CJ; Cuberos LF; Barry EM; Pasetti MF; Levine MM
    Vaccine; 2004 Sep; 22(27-28):3744-50. PubMed ID: 15315855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.
    Costa SM; Azevedo AS; Paes MV; Sarges FS; Freire MS; Alves AM
    Virology; 2007 Feb; 358(2):413-23. PubMed ID: 17020777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.
    Mellado-Sánchez G; García-Cordero J; Luria-Pérez R; Lázaro-Olan L; Santos-Argumedo L; Gutiérrez-Castañeda B; Estrada-García I; Cedillo-Barrón L
    Viral Immunol; 2005; 18(4):709-21. PubMed ID: 16359237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice.
    Morton M; Garmory HS; Perkins SD; O'Dowd AM; Griffin KF; Turner AK; Bennett AM; Titball RW
    Vaccine; 2004 Jun; 22(20):2524-32. PubMed ID: 15193377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection.
    Zheng Q; Fan D; Gao N; Chen H; Wang J; Ming Y; Li J; An J
    Vaccine; 2011 Jan; 29(4):763-71. PubMed ID: 21095256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Liu X; Hu J; Zhang X; Fan D
    Chin Med J (Engl); 2002 Oct; 115(10):1513-6. PubMed ID: 12490099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1.
    Ranasinghe C; Medveczky JC; Woltring D; Gao K; Thomson S; Coupar BE; Boyle DB; Ramsay AJ; Ramshaw IA
    Vaccine; 2006 Jul; 24(31-32):5881-95. PubMed ID: 16759767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen.
    Sim AC; Lin W; Tan GK; Sim MS; Chow VT; Alonso S
    Vaccine; 2008 Feb; 26(9):1145-54. PubMed ID: 18243432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus.
    Costa SM; Freire MS; Alves AM
    Vaccine; 2006 May; 24(21):4562-4. PubMed ID: 16140430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A heterologous prime-boost vaccination regimen using ORFF DNA and recombinant ORFF protein confers protective immunity against experimental visceral leishmaniasis.
    Tewary P; Jain M; Sahani MH; Saxena S; Madhubala R
    J Infect Dis; 2005 Jun; 191(12):2130-7. PubMed ID: 15898000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of pregnant sows with a novel virulence gene deleted live Salmonella vaccine and protection of their suckling piglets against salmonellosis.
    Hur J; Lee JH
    Vet Microbiol; 2010 Jul; 143(2-4):270-6. PubMed ID: 20031343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level expression of recombinant dengue viral NS-1 protein and its potential use as a diagnostic antigen.
    Huang JL; Huang JH; Shyu RH; Teng CW; Lin YL; Kuo MD; Yao CW; Shaio MF
    J Med Virol; 2001 Nov; 65(3):553-60. PubMed ID: 11596093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
    Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P
    Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence.
    Costa SM; Paes MV; Barreto DF; Pinhão AT; Barth OM; Queiroz JL; Armôa GR; Freire MS; Alves AM
    Vaccine; 2006 Jan; 24(2):195-205. PubMed ID: 16122850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.